Lariciresinol [CAS 27003-73-2]

Lariciresinol is an orally active ingredient. Lariciresinol can be isolated from Arabidopsis thaliana. Lariciresinol inhibits α-glucosidase activity (IC50 of 6.97 μM; Ki of 0.046 μM) . Lariciresinol dereases Bcl-2, upregulates Bax and induces Apoptosis. Lariciresinol regulates TGF-β and NF-κB pathways. Lariciresinol has antitumor activity against liver cancer, gastric cancer, and breast cancer. Lariciresinol shows antifungal activity and anti-diabetic activity[1][2][3][4][5][6][7][8].

[27003-73-2]

C20H24O6

360.4

OC[C@@H]1[C@](C(C=C2)=CC(OC)=C2O)([H])OC[C@@H]1CC(C=C3)=CC(OC)=C3O

Apoptosis; Bcl-2 Family; Fungal; Glycosidase; NF-κB; TGF-β Receptor

Glucosidase

99.79

DMSO : 100 mg/mL (ultrasonic) |Methanol : 25 mg/mL (ultrasonic)

4°C (Powder, protect from light)

Room Temperature

H400

H400